E
BIO-key International, Inc.
BKYI
$0.727
-$0.0261-3.47%
E
Sell
6/21/2024Upgraded
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 6/21/2024 due to a significant increase in the growth index and volatility index. Total revenue increased 135.78% from $925.1 to $2.18M, operating cash flow increased 119.4% from -$1.53M to $297.1, and earnings per share increased from -$8.4092 to -$0.3159.
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 6/21/2024 due to a significant increase in the growth index and volatility index. Total revenue increased 135.78% from $925.1 to $2.18M, operating cash flow increased 119.4% from -$1.53M to $297.1, and earnings per share increased from -$8.4092 to -$0.3159.
E
Sell
6/18/2024Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 6/18/2024 due to a major decline in the growth index and volatility index. Operating cash flow declined 818.72% from -$166.7 to -$1.53M, EBIT declined 752.12% from -$765.6 to -$6.52M, and earnings per share declined from -$1.2641 to -$8.4092.
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 6/18/2024 due to a major decline in the growth index and volatility index. Operating cash flow declined 818.72% from -$166.7 to -$1.53M, EBIT declined 752.12% from -$765.6 to -$6.52M, and earnings per share declined from -$1.2641 to -$8.4092.
E
Sell
6/4/2024Upgraded
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 6/4/2024 due to an increase in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 6/4/2024 due to an increase in the volatility index and total return index.
E
Sell
5/20/2024Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 5/20/2024 due to a decline in the volatility index.
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 5/20/2024 due to a decline in the volatility index.
E
Sell
5/3/2024Upgraded
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 5/3/2024 due to an increase in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 5/3/2024 due to an increase in the volatility index and total return index.
E
Sell
4/18/2024Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 4/18/2024 due to a decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 4/18/2024 due to a decline in the volatility index and total return index.
E
Sell
3/28/2024Upgraded
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 3/28/2024 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 3/28/2024 due to an increase in the volatility index.
E
Sell
3/13/2024Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 3/13/2024 due to a decline in the volatility index.
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 3/13/2024 due to a decline in the volatility index.
E
Sell
2/26/2024Upgraded
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 2/26/2024 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 2/26/2024 due to an increase in the volatility index.
E
Sell
2/8/2024Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 2/8/2024 due to a decline in the volatility index, growth index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 2/8/2024 due to a decline in the volatility index, growth index and total return index.
E
Sell
1/24/2024Upgraded
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 1/24/2024 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to E+ from E on 1/24/2024 due to an increase in the volatility index.
E
Sell
1/8/2024Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 1/8/2024 due to a substantial decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.61 to 0.53, and debt to equity increased from 0.77 to 0.83.
BIO-key International, Inc. (BKYI) was downgraded to E from E+ on 1/8/2024 due to a substantial decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.61 to 0.53, and debt to equity increased from 0.77 to 0.83.
E
Sell
3/14/2023Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D- from E+ on 02/23/2023.
BIO-key International, Inc. (BKYI) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
11/21/2022Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 11/21/2022 due to a decline in the growth index, solvency index and total return index. Operating cash flow declined 139.25% from -$853.1 to -$2.04M, EBIT declined 50.58% from -$1.57M to -$2.36M, and earnings per share declined from -$0.2123 to -$0.2948.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 11/21/2022 due to a decline in the growth index, solvency index and total return index. Operating cash flow declined 139.25% from -$853.1 to -$2.04M, EBIT declined 50.58% from -$1.57M to -$2.36M, and earnings per share declined from -$0.2123 to -$0.2948.
D
Sell
5/16/2022Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 05/13/2022.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index.
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index.
E
Sell
5/1/2022Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
E
Sell
4/20/2022Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and solvency index.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and solvency index.
D
Sell
11/10/2021Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 11/10/2021 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to D from E+ on 11/10/2021 due to an increase in the volatility index.
E
Sell
11/8/2021Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and total return index.
D
Sell
11/3/2021Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 11/3/2021 due to an increase in the volatility index and growth index.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 11/3/2021 due to an increase in the volatility index and growth index.
D
Sell
10/18/2021Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 10/18/2021 due to a decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 10/18/2021 due to a decline in the volatility index and total return index.
D
Sell
9/29/2021Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 9/29/2021 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 9/29/2021 due to an increase in the volatility index.
D
Sell
9/13/2021Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 9/13/2021 due to a major decline in the growth index, volatility index and valuation index. Total revenue declined 47.47% from $1.89M to $992.1, earnings per share declined from -$0.1095 to -$0.15, and EBIT declined 33.07% from -$836 to -$1.11M.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 9/13/2021 due to a major decline in the growth index, volatility index and valuation index. Total revenue declined 47.47% from $1.89M to $992.1, earnings per share declined from -$0.1095 to -$0.15, and EBIT declined 33.07% from -$836 to -$1.11M.
D
Sell
4/5/2021Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 4/5/2021 due to a significant increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.5118 to -$0.185, operating cash flow increased 26.36% from -$1.72M to -$1.26M, and total revenue increased 12.77% from $943.3 to $1.06M.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 4/5/2021 due to a significant increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.5118 to -$0.185, operating cash flow increased 26.36% from -$1.72M to -$1.26M, and total revenue increased 12.77% from $943.3 to $1.06M.
D
Sell
11/20/2020Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D- from E+ on 11/20/2020 due to a significant increase in the solvency index, valuation index and growth index. The quick ratio increased from 0.39 to 9.97, total revenue increased 207.16% from $307.1 to $943.3, and debt to equity declined from 3.8 to 0.02.
BIO-key International, Inc. (BKYI) was upgraded to D- from E+ on 11/20/2020 due to a significant increase in the solvency index, valuation index and growth index. The quick ratio increased from 0.39 to 9.97, total revenue increased 207.16% from $307.1 to $943.3, and debt to equity declined from 3.8 to 0.02.
E
Sell
10/6/2020Downgrade
BIO-key International, Inc. (BKYI) was downgraded to E+ from D- on 10/6/2020 due to a decline in the volatility index, total return index and growth index.
BIO-key International, Inc. (BKYI) was downgraded to E+ from D- on 10/6/2020 due to a decline in the volatility index, total return index and growth index.
D
Sell
8/14/2020Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 8/14/2020 due to a decline in the valuation index, growth index and total return index. Total revenue declined 41.22% from $522.5 to $307.1, and EBIT declined 3.92% from -$1.32M to -$1.37M.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 8/14/2020 due to a decline in the valuation index, growth index and total return index. Total revenue declined 41.22% from $522.5 to $307.1, and EBIT declined 3.92% from -$1.32M to -$1.37M.
D
Sell
6/29/2020Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 6/29/2020 due to an increase in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 6/29/2020 due to an increase in the volatility index and total return index.
D
Sell
6/12/2020Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 6/12/2020 due to a decline in the volatility index and solvency index.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 6/12/2020 due to a decline in the volatility index and solvency index.
D
Sell
6/9/2020Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 6/9/2020 due to an increase in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 6/9/2020 due to an increase in the volatility index and total return index.
D
Sell
5/20/2020Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 5/20/2020 due to a substantial decline in the solvency index and growth index. Earnings per share declined from -$0.1272 to -$0.6616, EBIT declined 70.06% from -$1.27M to -$2.16M, and the quick ratio declined from 0.44 to 0.19.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 5/20/2020 due to a substantial decline in the solvency index and growth index. Earnings per share declined from -$0.1272 to -$0.6616, EBIT declined 70.06% from -$1.27M to -$2.16M, and the quick ratio declined from 0.44 to 0.19.
D
Sell
5/1/2020Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 5/1/2020 due to an increase in the total return index.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 5/1/2020 due to an increase in the total return index.
D
Sell
4/8/2019Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 4/8/2019 due to a decline in the efficiency index and volatility index. Total capital declined 11.23% from $11.79M to $10.47M.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 4/8/2019 due to a decline in the efficiency index and volatility index. Total capital declined 11.23% from $11.79M to $10.47M.
D
Sell
2/1/2019Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 2/1/2019 due to an increase in the volatility index.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 2/1/2019 due to an increase in the volatility index.
D
Sell
1/17/2019Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 1/17/2019 due to a large decline in the growth index, total return index and efficiency index. Earnings per share declined from -$0.1492 to -$0.2336, operating cash flow declined 7.62% from -$944.8 to -$1.02M, and total revenue declined 1.11% from $748.1 to $739.8.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 1/17/2019 due to a large decline in the growth index, total return index and efficiency index. Earnings per share declined from -$0.1492 to -$0.2336, operating cash flow declined 7.62% from -$944.8 to -$1.02M, and total revenue declined 1.11% from $748.1 to $739.8.
D
Sell
4/5/2018Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 4/5/2018 due to a major increase in the growth index, efficiency index and solvency index. Total revenue increased 224.21% from $942.4 to $3.06M, EBIT increased 129.64% from -$1.61M to $476, and net income increased 129.64% from -$1.61M to $476.
BIO-key International, Inc. (BKYI) was upgraded to D from D- on 4/5/2018 due to a major increase in the growth index, efficiency index and solvency index. Total revenue increased 224.21% from $942.4 to $3.06M, EBIT increased 129.64% from -$1.61M to $476, and net income increased 129.64% from -$1.61M to $476.
D
Sell
11/15/2017Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 11/15/2017 due to a large decline in the total return index and volatility index.
BIO-key International, Inc. (BKYI) was downgraded to D- from D on 11/15/2017 due to a large decline in the total return index and volatility index.
D
Sell
8/16/2017Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 8/16/2017 due to a decline in the solvency index, growth index and valuation index. Operating cash flow declined 928.12% from $117 to -$968.9, total revenue declined 37.47% from $1.42M to $886.9, and EBIT declined 31.93% from -$1.36M to -$1.79M.
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 8/16/2017 due to a decline in the solvency index, growth index and valuation index. Operating cash flow declined 928.12% from $117 to -$968.9, total revenue declined 37.47% from $1.42M to $886.9, and EBIT declined 31.93% from -$1.36M to -$1.79M.
D
Sell
7/7/2017Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 7/7/2017 due to an increase in the growth index, total return index and valuation index. Operating cash flow increased 112.67% from -$923.8 to $117.
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 7/7/2017 due to an increase in the growth index, total return index and valuation index. Operating cash flow increased 112.67% from -$923.8 to $117.
D
Sell
8/16/2016Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 8/16/2016 due to a significant decline in the efficiency index and growth index. Operating cash flow declined 86.5% from -$661.6 to -$1.23M, net income declined 18.25% from -$1.16M to -$1.38M, and earnings per share declined from -$0.0206 to -$0.0238.
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 8/16/2016 due to a significant decline in the efficiency index and growth index. Operating cash flow declined 86.5% from -$661.6 to -$1.23M, net income declined 18.25% from -$1.16M to -$1.38M, and earnings per share declined from -$0.0206 to -$0.0238.
D
Sell
6/13/2016Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 6/13/2016 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 3.42 to 3.44.
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 6/13/2016 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 3.42 to 3.44.
D
Sell
5/13/2016Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 5/13/2016 due to a decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 5/13/2016 due to a decline in the volatility index and total return index.
D
Sell
4/4/2016Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 4/4/2016 due to a significant increase in the efficiency index, solvency index and growth index. Total capital increased 4,095.54% from $432.6 to $18.15M, the quick ratio increased from 0.76 to 3.42, and total revenue increased 149.3% from $669.8 to $1.67M.
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 4/4/2016 due to a significant increase in the efficiency index, solvency index and growth index. Total capital increased 4,095.54% from $432.6 to $18.15M, the quick ratio increased from 0.76 to 3.42, and total revenue increased 149.3% from $669.8 to $1.67M.
D
Sell
3/11/2016Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 3/11/2016 due to a major decline in the volatility index and total return index.
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 3/11/2016 due to a major decline in the volatility index and total return index.
D
Sell
11/27/2015Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D+ from C on 11/27/2015 due to a significant decline in the efficiency index and valuation index.
BIO-key International, Inc. (BKYI) was downgraded to D+ from C on 11/27/2015 due to a significant decline in the efficiency index and valuation index.
C
Hold
11/18/2015Upgraded
BIO-key International, Inc. (BKYI) was upgraded to C from D on 11/18/2015 due to a significant increase in the efficiency index and valuation index.
BIO-key International, Inc. (BKYI) was upgraded to C from D on 11/18/2015 due to a significant increase in the efficiency index and valuation index.
D
Sell
8/14/2015Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 8/14/2015 due to a decline in the solvency index, efficiency index and valuation index. Total capital declined 3,293.25% from -$23.7 to $756.8, and net income declined 181.5% from -$924.1 to $753.1.
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 8/14/2015 due to a decline in the solvency index, efficiency index and valuation index. Total capital declined 3,293.25% from -$23.7 to $756.8, and net income declined 181.5% from -$924.1 to $753.1.
D
Sell
5/5/2015Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 5/5/2015 due to an increase in the volatility index and valuation index.
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 5/5/2015 due to an increase in the volatility index and valuation index.
D
Sell
4/6/2015Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from C on 4/6/2015 due to a significant decline in the efficiency index, total return index and valuation index. Total capital declined 388.41% from -$263.2 to $759.1.
BIO-key International, Inc. (BKYI) was downgraded to D from C on 4/6/2015 due to a significant decline in the efficiency index, total return index and valuation index. Total capital declined 388.41% from -$263.2 to $759.1.
C
Hold
11/25/2014Upgraded
BIO-key International, Inc. (BKYI) was upgraded to C from C- on 11/25/2014 due to a large increase in the growth index, efficiency index and solvency index. Operating cash flow increased 371.7% from -$73.5 to -$346.7, total revenue increased 218.72% from $402.8 to $1.28M, and total capital increased 11.95% from -$235.1 to -$263.2.
BIO-key International, Inc. (BKYI) was upgraded to C from C- on 11/25/2014 due to a large increase in the growth index, efficiency index and solvency index. Operating cash flow increased 371.7% from -$73.5 to -$346.7, total revenue increased 218.72% from $402.8 to $1.28M, and total capital increased 11.95% from -$235.1 to -$263.2.
C
Hold
11/3/2014Downgrade
BIO-key International, Inc. (BKYI) was downgraded to C- from C on 11/3/2014 due to a major decline in the volatility index.
BIO-key International, Inc. (BKYI) was downgraded to C- from C on 11/3/2014 due to a major decline in the volatility index.
C
Hold
8/22/2014Upgraded
BIO-key International, Inc. (BKYI) was upgraded to C from D+ on 8/22/2014 due to a significant increase in the efficiency index, valuation index and total return index. Net income increased 243.01% from -$299.2 to -$1.03M.
BIO-key International, Inc. (BKYI) was upgraded to C from D+ on 8/22/2014 due to a significant increase in the efficiency index, valuation index and total return index. Net income increased 243.01% from -$299.2 to -$1.03M.
D
Sell
8/1/2014Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 8/1/2014 due to an increase in the valuation index.
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 8/1/2014 due to an increase in the valuation index.
D
Sell
7/17/2014Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 7/17/2014 due to a major decline in the total return index.
BIO-key International, Inc. (BKYI) was downgraded to D from D+ on 7/17/2014 due to a major decline in the total return index.
D
Sell
5/23/2014Upgraded
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 5/23/2014 due to a noticeable increase in the total return index, growth index and solvency index. Total revenue increased 317.56% from $327.5 to $1.37M, and operating cash flow increased 38.84% from -$919.5 to -$1.28M.
BIO-key International, Inc. (BKYI) was upgraded to D+ from D on 5/23/2014 due to a noticeable increase in the total return index, growth index and solvency index. Total revenue increased 317.56% from $327.5 to $1.37M, and operating cash flow increased 38.84% from -$919.5 to -$1.28M.
D
Sell
4/7/2014Downgrade
BIO-key International, Inc. (BKYI) was downgraded to D from C- on 4/7/2014 due to a major decline in the growth index, efficiency index and valuation index. Total capital declined 333.12% from -$450.8 to $1.05M, total revenue declined 24.12% from $431.6 to $327.5, and earnings per share declined from -$0.0087 to -$0.0086.
BIO-key International, Inc. (BKYI) was downgraded to D from C- on 4/7/2014 due to a major decline in the growth index, efficiency index and valuation index. Total capital declined 333.12% from -$450.8 to $1.05M, total revenue declined 24.12% from $431.6 to $327.5, and earnings per share declined from -$0.0087 to -$0.0086.
C
Hold
3/12/2014Upgraded
BIO-key International, Inc. (BKYI) was upgraded to C- from D+ on 3/12/2014 due to a noticeable increase in the valuation index and growth index.
BIO-key International, Inc. (BKYI) was upgraded to C- from D+ on 3/12/2014 due to a noticeable increase in the valuation index and growth index.
NASDAQ
04/11/2025 4:00PM Eastern
Quotes delayed